You can feel completely fine and still be in the early innings of metabolic change. That's not scare talk—it's just how the body's blood-sugar system works, and it's exactly why a real baseline in your 20s, 30s, or 40s tells you more than waiting until something “feels wrong.”
Two numbers get thrown around a lot: fasting insulin and HbA1c. They sound related, and they are, but they measure different things on different timelines. Understanding the difference is one of the more useful things you can do with a first lab panel—no supplement funnel required.
The one-sentence version
HbA1c estimates your average blood sugar over roughly the past three months. Fasting insulin reflects how hard your pancreas is working to keep that blood sugar normal right now. One is the outcome; the other is the effort behind the outcome.
That distinction matters because the effort can rise long before the outcome moves.
Source: [1] MedlinePlus: Hemoglobin A1C (HbA1c) Test, [3] Freeman AM, et al. Insulin Resistance. StatPearls, NIH National Library of Medicine
HbA1c: the three-month average
Hemoglobin is the protein in red blood cells that carries oxygen. When glucose is in your bloodstream, some of it sticks to hemoglobin—a process called glycation. Because red blood cells live about three months, measuring the *glycated* fraction (HbA1c) gives a rolling average of your glucose exposure over that window [1].
The American Diabetes Association describes commonly used HbA1c categories: below 5.7% is considered normal, 5.7% to 6.4% falls in the prediabetes range, and 6.5% or higher on two tests is one criterion used in diagnosing diabetes [2].
HbA1c is popular for good reasons: no fasting required, one blood draw, and it's standardized. But it has a lag. By the time HbA1c drifts up, the underlying system has often been compensating for a while. A few conditions—anemia, certain hemoglobin variants, recent blood loss, pregnancy—can also skew the reading, which is one reason a provider interprets it in context rather than in isolation [1].
% HbA1c · marker = Prediabetes starts
Source: [2] American Diabetes Association: Understanding A1C Diagnosis
Fasting insulin: the effort meter
Insulin is the hormone that moves glucose out of the blood and into cells. When cells respond less readily to insulin—a state called insulin resistance—the pancreas often responds by making *more* insulin to keep glucose in range. So for a period of time, glucose (and therefore HbA1c) can look perfectly normal precisely *because* insulin is running high to hold the line [3].
That's the key idea: fasting insulin can rise while HbA1c stays flat. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains that insulin resistance and elevated insulin can be present for years before blood glucose crosses into prediabetes or diabetes territory [4].
Fasting insulin doesn't have a single universally agreed-upon “optimal” cutoff the way HbA1c has diagnostic thresholds, which is part of why it's read alongside glucose rather than alone. Providers sometimes pair fasting insulin and fasting glucose to estimate insulin resistance using a calculation called HOMA-IR, a research-derived index that helps put the two numbers into one picture [5].
Why one moves before the other
Think of it as a sequence, not a switch. Early on, cells become somewhat less responsive to insulin. The pancreas compensates by secreting more insulin, and glucose stays normal. Fasting insulin (and HOMA-IR) may be the first thing that nudges upward. Only later, if the pancreas can't keep up, does fasting glucose—and eventually HbA1c—begin to rise [3][4].
This is why a normal HbA1c in your late 20s or 40s is genuinely reassuring *and* not the whole story. Looking at insulin adds an earlier, more sensitive vantage point—information, not a diagnosis.
Source: [3] Freeman AM, et al. Insulin Resistance. StatPearls, NIH National Library of Medicine, [4] NIDDK: Insulin Resistance & Prediabetes
What this means for a first baseline
A few honest, practical points:
- A single number rarely tells a story. Providers read fasting insulin and HbA1c together, usually alongside fasting glucose and a lipid panel, and against your history—sleep, stress, medications, family history, menstrual and hormonal patterns.
- “Normal” and “optimal” aren't always the same conversation. Reference ranges flag disease thresholds; a longevity-minded reading also considers trends over time. That's why baselines in your 20s and 30s are valuable—they give future-you a comparison point.
- Context changes interpretation. For example, polycystic ovary syndrome (PCOS) is commonly associated with insulin resistance, and skin and cycle symptoms can be part of that broader picture. The Endocrine Society notes the link between insulin resistance and PCOS features [6]. That doesn't mean a breakout equals a diagnosis—it means these numbers can be one piece of a larger conversation with a provider who actually asks questions.
This article is educational and is not medical advice. Only an independent, licensed provider can interpret your labs and decide what, if anything, they mean for you.
What a good lab conversation sounds like
You don't need to arrive fluent in endocrinology. A useful visit is less about a single result and more about interpretation: *Given my numbers, my history, and how I actually feel, what's worth watching, and what's worth doing nothing about right now?* Sometimes the most valuable outcome is a clear “your baseline looks solid—let's recheck in a year.” That's not a letdown; that's data working for you instead of against you.
And if something does warrant follow-up, the point is a plan and a person, not a product—being taken seriously, having your fatigue or your skin actually explored rather than waved off, and knowing someone will remember the details next time.
Where Velri fits
Velri is a technology and coordination company—not a medical practice. What Velri does is remove the runaround: we help coordinate lab work, connect you with an independent, licensed provider who can review your results with you (including baseline metabolic markers like fasting insulin, fasting glucose, and HbA1c in context), and—if that independent provider determines a prescription is appropriate—coordinate fulfillment through an independent, licensed pharmacy.
Care is always provided by the independent provider, and a prescription is never guaranteed; it's a clinical decision made by a licensed professional. If a compounded medication is ever discussed as part of your care, note that compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
The goal isn't to sell you a number. It's to help you understand the ones you have—and to give you a care team you can actually talk to, and grow with, over time.
